Modern approaches for developing antivirals against SARS-CoV 2
economy. To provide frontline therapies for COVID-19 and future corona virus outbreaks requires a concerted effort of
different disciplines, technologies, high security labs, and rapid translation of scientific findings to highly innovative and
“hungry” SME partners. For the MAD-CoV-2 project we have assembled a multidisciplinary team of world-leading
researchers and innovative industry partners to unlock the Achille’s heels of the virus infections in host cells and rapidly
translate such knowledge into disruptive new medicines and public health measures. Our team members have been on the
supporting all other efforts.